Want to see HK:2496 full AI Analyst Report?

Wuhan YZY Biopharma Co., Ltd. Class H (2496) Revenue

1 Followers

Wuhan YZY Biopharma Co., Ltd. Class H Revenue

Wuhan YZY Biopharma Co., Ltd. Class H had a revenue of 32.69M in the quarter ending Jun 30, 2026, with 97.24%. This bring the company's revenue in the last twelve months to 89.68M, Decreased 13.26%. In the fiscal year ending Dec 31, 2025, Wuhan YZY Biopharma Co., Ltd. Class H had annual revenue of 65.13M with -39.59% growth.

Revenue (ttm)

89.68M

Revenue Growth

-55.22%

P/S Ratio

8.87

Revenue/Employee

HK$614,412

Employees

106

Market Cap

HK$577.40M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	65.13M	-42.69M	-39.59%
Dec 31, 2024	107.81M	95.89M	+804.31%
Dec 31, 2023	11.92M	9.65M	+423.59%
Dec 31, 2022	2.28M	-9.90M	-81.30%
Dec 31, 2021	12.18M	―	+∞%
Dec 31, 2020	―	―	―